CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | RENTON HOLLINGS Director | Option exercise 10b5-1 | +5,000 | $18.03 | $90K | 15,995 |
| 2026-10-01 | RENTON HOLLINGS Director | Sale 10b5-1 | −5,000 | $49.87 | $249K | 10,995 |
| 2026-10-01 | RENTON HOLLINGS Director | Option exercise · Common Stock 10b5-1 | −5,000 | 10,000 | ||
| 2026-09-15 | Orwin John A Director | Option exercise | +1,300 | 17,995 | ||
| 2026-09-15 | Orwin John A Director | Option exercise · Restricted Stock Unit | −1,300 | 0 | ||
| 2026-06-15 | Schmid John P. Director | Option exercise | +6,030 | 37,652 | ||
| 2026-06-15 | Schmid John P. Director | Option exercise · Restricted Stock Unit | −6,030 | 0 | ||
| 2026-06-15 | Orwin John A Director | Option exercise | +6,030 | 16,695 | ||
| 2026-06-15 | Orwin John A Director | Option exercise · Restricted Stock Unit | −6,030 | 0 | ||
| 2026-06-15 | RENTON HOLLINGS Director | Option exercise | +6,030 | 10,995 | ||
| 2026-06-15 | RENTON HOLLINGS Director | Option exercise · Restricted Stock Unit | −6,030 | 0 | ||
| 2026-05-11 | Murphy Christopher M. Chief Financial Officer | Grant or award · Restricted Stock Units | +25,765 | 25,765 | ||
| 2026-05-11 | Hughes Owen Director | Grant or award · Restricted Stock Units | +11,250 | 11,250 | ||
| 2026-04-27 | GRAY SUSANNAH Director | Grant or award · Restricted Stock Unit | +11,250 | 11,250 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −11,000 | 11,000 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −11,000 | 16,510 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −2,321 | 2,321 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +2,321 | 2,321 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −9,200 | 9,200 |
Page 1 of 17 · 339 trades